Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares for the month of October 2025. The filing details a share repurchase executed on October 7, 2025, acting through BNP Paribas SA as the broker. The transaction is part of the Company's existing buyback programme, governed by a non-discretionary agreement announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing focuses exclusively on capital structure changes via share repurchase rather than operational financial performance. Key metrics for the transaction are as follows:
- Shares Purchased: 354,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,597.50p; highest price paid was 1,611.50p.
- Volume-Weighted Average Price (VWAP): 1,603.99p per share.
- Trading Venues: Purchases were executed across BATE, CHIX, and XLON (London Stock Exchange).
- Treasury Shares: Following this purchase, the Company holds 249,410,844 ordinary shares in treasury.
- Shares in Issue: 4,065,997,695 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 6.13% of the total voting rights.
Material Changes Versus Prior Period
Since the announcement of the non-discretionary agreement on September 30, 2025, the Company has purchased an aggregate of 1,946,000 ordinary shares. This specific filing represents the incremental purchase activity for October 7, 2025, contributing to the reduction of shares in issue and the increase in treasury holdings.
Guidance, Outlook, and Risks
The filing contains no operational guidance, revenue outlook, or management commentary regarding business performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the Company's Annual Report on Form 20-F for 2024 and Q2 Results for 2025. The purchased shares are held as Treasury shares and do not carry voting rights.
Important Facts for Investor Verification
- Verify the total number of shares in issue (4,065,997,695) for accurate calculation of ownership percentages under FCA Disclosure Guidance and Transparency Rules.
- Confirm the treasury share percentage (6.13%) to understand the dilution impact on voting rights.
- Note that the buyback is executed via a non-discretionary agreement, implying a systematic approach to repurchasing shares.
- Review the specific trading venues (BATE, CHIX, XLON) to understand market liquidity utilization.